Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

People with HIV offered hope of self-injected drug at home

GSK-controlled company works on developing patient-administered treatment by end of the decade

The Guardian - UK

$A fractured UN is still notching wins with corporate sector$

A fractured UN is still notching wins with corporate sector

This week, the UN convinced companies to report new nature-related disclosures.

Fortune

Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival

Incyte stock tumbled to a nearly five-year low Monday after GSK gained FDA approval for a rival myelofibrosis treatment.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Surges After Flu Shot Beats Out Widely Used Sanofi, GSK Vaccines

Moderna said Wednesday its flu shot outperformed broadly used vaccines from Sanofi and GSK. The results bolstered Moderna stock.

Investors Business Daily

3 Pharma Stocks for Value Investors

The aging global population and the growing demand for drugs and therapies to treat chronic diseases are boosting the long-term prospects of the pharmaceutical industry. Amid this backdrop, value investors could consider buying fundamentally strong pharma stocks GSK plc (GSK), Horizon Therapeutics (HZNP), and Neurocrine Biosciences (NBIX), as they are…

StockNews.com

More babies will need hospital treatment over RSV vaccine delay, says top doctor

The Medicines and Healthcare products Regulatory Agency (MHRA) approved GSK’s jab, known as Arexvy, for use among older adults in July.

The Independent UK

How Vivek Ramaswamy, the surprise GOP debate star, made his fortune and triggered his critics

He bills himself as an iconoclast ready to shake up the Republican Party after making millions trying to do the same in the biotech industry.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Who should get the new RSV vaccines? Here's everything you need to know

There are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?

LiveScience

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

StockNews.com

An Under the Radar Healthcare Stock to Add to Your Portfolio

The era of the giant pharmaceutical conglomerate is coming to a close, but consumer-focused Haleon stock looks set to deliver healthy returns through long-term economic cycles.

Barchart

Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General Medicines

Pharmaceutical giant GSK beat expectations for the second quarter and raised its forecast for the full year.

Investors Business Daily

FTSE 100 Live: NatWest boss out, Ocado shares surge further, Fed ups rates but markets hope it’s last hike

The turmoil at NatWest, half-year figures by Lloyds and profit upgrades at GSK and Rolls-Royce are just some of today’s big blue-chip developments.

Evening Standard

GSK leadership team meets KTR

The GSK team was excited to learn about the growth of the Lifesciences sector in Telangana and how global companies are leveraging the ecosystem.

The Hindu

‘This feels exactly the right place to be’: Sir Patrick Vallance on pandemics, eco-anxiety and leading the Natural History Museum

The UK’s former chief scientific adviser, a familiar face during Covid, talks about his new role as chair of the London museum and putting its collection at the heart of our climate response

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

Evening Standard

RSV vaccine for over-60s on the horizon after regulatory approval

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

The Independent UK

Jab for common illness among over-60s on the horizon after regulatory approval

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

Wales Online

New vaccine for disease that kills 8,000 over 60s in UK every year

The vaccine will help cut up to 175,000 GP visits

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Evening Standard

Tech spending: The companies on London’s blue chip index exploring AI

A host of FTSE 100 companies are among businesses planning to invest in AI

The Independent UK

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

The Guardian - UK

‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials

Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases

Tribune News Service

Gonorrhea shot gets FDA fast track as resistant cases multiply

GSK Plc’s experimental gonorrhea vaccine got fast-track designation from U.S. regulators, putting the shot in position to become the first preventive for a common, often-undetected infection that’s gaining resistance to treatment.

Investors Business Daily

GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms

GSK stock jumped Friday after the British drugmaker said it settled one of thousands of claims that its heartburn drug Zantac caused cancer.

Evening Standard

How big pharma is using AI to untangle the language of DNA

AI-powered tools are rapidly transforming the world of drug discovery

1 … 5 6 7 8

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.